Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-EN | Version v5-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2025-08-06 | 2025-08-06 |
| Drug Identification Number | 02480549 | 02480549 |
| Brand name | FEIBA NF | FEIBA NF |
| Common or Proper name | Testing Yannick | Testing Yannick |
| Company Name | TAKEDA CANADA INC | TAKEDA CANADA INC |
| Ingredients | ANTI-INHIBITOR COAGULANT COMPLEX | ANTI-INHIBITOR COAGULANT COMPLEX |
| Strength(s) | 650UNIT | 650UNIT |
| Dosage form(s) | POWDER FOR SOLUTION KIT | POWDER FOR SOLUTION KIT |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | large | large |
| ATC code | B02BD | B02BD |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
| Anticipated start date | 2020-01-01 | 2020-01-01 |
| Actual start date | ||
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Company comments | Company comments |
| Health Canada comments | Health Canada comments | Health Canada comments |